Form 4 for NUTX Nutex Health Inc.
Accepted 2024-03-14 00:00:00 ET · period of report 2024-03-12 · accession 0001486189-24-000020 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-14 | 2024-03-12 | NUTX | Bates Jon Christian | CFO | M - OptEx | — | +49.5K | 139.0K | +55% | — |
| D | 2024-03-14 | 2024-03-12 | NUTX | Bates Jon Christian | CFO | M - OptEx | $0.00 | -49.5K | 49.5K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-12 | M | A | 49,505 | — | 139,010 | D | — | — | (F2) Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting. |
| 2 | Derivative | Restricted Stock Units | 2024-03-12 | M | D | 49,505 | $0.00 | 49,505 | D | — · — to — | 49,505 Common Stock | (F2) Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting. (F3) Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Mr. Bates, dated April 1, 2023, the 148,515 RSUs granted to Mr. Bates will vest in three equal installments, with the initial 1/3 immediately vested on April 1, 2023, and the remaining RSUs vesting 1/3 each on March 1, 2024 and March 1, 2025 |